Company Filing History:
Years Active: 1990-1992
Title: Kiyoshi Matsumoto: Innovator in Antitumor Antibiotics
Introduction
Kiyoshi Matsumoto is a notable inventor based in Kawaguchi, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antitumor antibiotics. With a total of 3 patents, Matsumoto's work has had a profound impact on cancer treatment.
Latest Patents
Matsumoto's latest patents include the BU-3420T antitumor antibiotic. This novel antibiotic is produced by the fermentation of the Micromonospora chersina strain M956-1 (ATCC 53710). The BU-3420T and its triacetate derivative exhibit both antibacterial and antifungal activity. Additionally, they inhibit the growth of mammalian tumors, such as P388 leukemia in mice. Another patent related to BU-3420T highlights its antifungal properties, reinforcing its potential in medical applications.
Career Highlights
Kiyoshi Matsumoto is associated with Bristol-Myers Company, where he has been instrumental in advancing research in antitumor antibiotics. His innovative approaches have led to breakthroughs that could change the landscape of cancer treatment.
Collaborations
Matsumoto has collaborated with esteemed colleagues, including Hiroaki Ohkuma and Masataka Konishi. Their combined expertise has fostered a productive research environment, leading to significant advancements in their field.
Conclusion
Kiyoshi Matsumoto's contributions to the development of antitumor antibiotics exemplify the importance of innovation in medicine. His work continues to inspire future research and development in the fight against cancer.